Drug Export Legislation
Executive SummaryChairman Hatch's Senate Labor & Human Resources Cmte. is planning June 5 hearings on the export issue to get the legislative process started. Early June date was chosen to fit Sen. Kennedy's schedule. Kennedy could be a key figure in assuring consideration of the bill by Chairman Waxman's House Health Subcmte. Kennedy has been more favorably inclined to overseas use of U.S. drugs since his recent tour of African relief sites.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.